Oil prices are significantly underpriced and should be much higher than current levels if the U.S. proceeds with a planned ...

Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Q1 2026 earnings face high 13% growth targets amid AI capex shifts, energy shocks, and a private credit liquidity crunch. Read more on geopolitical risks here.

Diversified hands-off retirement portfolio: 12 funds (ETFs/CEFs/mutual) targeting 6% yield + 6% dividend growth. Read the ...

Abercrombie & Fitch's cleaner inventory position enables selective pricing and reduces the risk of margin-eroding promotions.

GE HealthCare's modest growth, margin expansion, and reduced leverage offset recent sluggish share performance. Read more on ...

John Hancock Diversified Macro Fund faced Q4 losses from fixed income and equity positions. Read the full analysis for more ...

U.S. Central Command posted Sunday that it will begin enforcing a maritime blockade on all traffic entering and exiting ...

Trump threatens 50% China tariffs over Iran aid and orders Strait of Hormuz blockade, spiking oil prices and recession ...

GE Vernova (GEV) looks structurally mispriced amid an AI-driven power demand supercycle—$150 billion backlog, ...